Efficacy and Safety Is Maintained in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria Receiving Pegcetacoplan for Up to 3 Years (AAMDSIF BMF 2024 PNH) - Apellis Medical Hub

Efficacy and Safety Is Maintained in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria Receiving Pegcetacoplan for Up to 3 Years

Share Via Email

PNH Congress Presentations International AAMDSIF Bone Marrow Failure Disease Scientific Symposium (AAMDSIF BMF) 2024

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.

Back to Conference Resources